| Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy PA Beavis, MA Henderson, L Giuffrida, JK Mills, K Sek, RS Cross, ... The Journal of clinical investigation 127 (3), 929-941, 2017 | 293 | 2017 |
| Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity AJ Davenport, RS Cross, KA Watson, Y Liao, W Shi, HM Prince, ... Proceedings of the National Academy of Sciences 115 (9), E2068-E2076, 2018 | 269 | 2018 |
| CAR-T cells inflict sequential killing of multiple tumor target cells AJ Davenport, MR Jenkins, RS Cross, CS Yong, HM Prince, DS Ritchie, ... Cancer immunology research 3 (5), 483-494, 2015 | 126 | 2015 |
| Dual-specific chimeric antigen receptor T cells and an indirect vaccine eradicate a variety of large solid tumors in an immunocompetent, self-antigen setting CY Slaney, B Von Scheidt, AJ Davenport, PA Beavis, JA Westwood, ... Clinical cancer research 23 (10), 2478-2490, 2017 | 112 | 2017 |
| Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma NA Gherardin, L Loh, L Admojo, AJ Davenport, K Richardson, A Rogers, ... Scientific reports 8 (1), 4159, 2018 | 90 | 2018 |
| A multifunctional role for adjuvant anti-4-1BB therapy in augmenting antitumor response by chimeric antigen receptor T cells S Mardiana, LB John, MA Henderson, CY Slaney, B von Scheidt, ... Cancer research 77 (6), 1296-1309, 2017 | 69 | 2017 |
| Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells PA Beavis, MA Henderson, L Giuffrida, AJ Davenport, EV Petley, ... Cancer immunology research 6 (9), 1069-1081, 2018 | 60 | 2018 |
| Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein RS Cross, J Malaterre, AJ Davenport, S Carpinteri, RL Anderson, ... Clinical & translational immunology 4 (1), e30, 2015 | 51 | 2015 |
| CAR-T cells are serial killers AJ Davenport, MR Jenkins, DS Ritchie, HM Prince, JA Trapani, ... Oncoimmunology 4 (12), e1053684, 2015 | 18 | 2015 |
| CAR-T cells inflict sequential killing of multiple tumor target cells. Cancer Immunol. Res. 2015; 3: 483–494. doi: 10.1158/2326-6066 AJ Davenport, MR Jenkins, RS Cross, CS Yong, HM Prince, DS Ritchie, ... CIR-15-0048.[Abstract][CrossRef][Google Scholar], 0 | 16 | |
| Programming a serial killer: CAR T cells form non-classical immune synapses AJ Davenport, MR Jenkins Oncoscience 5 (3-4), 69, 2018 | 12 | 2018 |
| Accelerated precipitate coarsening due to a concomitant secondary phase transformation IW Chen, A Davenport, L Wang Acta materialia 51 (6), 1691-1703, 2003 | 11 | 2003 |
| Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor MA Henderson, CSM Yong, CPM Duong, AJ Davenport, LB John, ... Immunotherapy 5 (6), 577-590, 2013 | 8 | 2013 |
| An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy JA Westwood, S Ellis, J Danne, C Johnson, V Oorschot, G Ramm, ... Oncotarget 8 (70), 115215, 2017 | 6 | 2017 |
| Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib PJ Neeson, AK Hsu, YR Chen, HM Halse, J Loh, R Cordy, K Fielding, ... Oncoimmunology 4 (9), e1038011, 2015 | 5 | 2015 |
| HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma SS Wang, AJ Davenport, M Iliopoulos, HE Hughes-Parry, KA Watson, ... Neuro-Oncology Advances 5 (1), vdad024, 2023 | 3 | 2023 |
| Bigger, stronger, faster: chimeric antigen receptor T cells are olympic killers PJ Neeson, AJ Davenport, JA Trapani, M Kershaw, R Cross, HM Prince, ... Blood 128 (22), 814, 2016 | 3 | 2016 |
| Dual-specific T cells and oncolytic virus eradicate large solid tumors CY Slaney, B Von Scheidt, PA Beavis, AJ Davenport, JA Westwood, ... European Journal of Immunology 46, 829-829, 2016 | 2 | 2016 |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma K Pandey, SS Wang, NA Mifsud, P Faridi, AJ Davenport, AI Webb, ... Frontiers in Oncology 13, 1192448, 2023 | 1 | 2023 |
| Super‐killer CTLs are generated by single gene deletion of Bach2 PR Barton, AJ Davenport, J Hukelmann, DA Cantrell, JC Stinchcombe, ... European Journal of Immunology 52 (11), 1776-1788, 2022 | 1 | 2022 |
